Bristol Myers Squibb Co. (BMY)

56.48 +0.91 (+1.64%) USD  |  NYSE  |  Jun 09, 16:00
56.42 -0.06 (-0.11%) After-Hours: 18:41
More

Bristol Myers Squibb SG&A Expense (Quarterly) : 1.617B for March 31, 2026

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for BMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Johnson & Johnson 6.034B
Eli Lilly & Co. 2.934B
Merck & Co., Inc. 2.70B
Pfizer Inc. 2.961B
Viatris, Inc. 928.80M